Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunoprecipitation01:20

Immunoprecipitation

7.6K
Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pleiotropic effects of double filtration plasmapheresis.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·2024
Same author

In vivo optical imaging of tumor stromal cells with hypoxia-inducible factor activity.

Cancer science·2023
Same author

Tissue-resident macrophages are major tumor-associated macrophage resources, contributing to early TNBC development, recurrence, and metastases.

Communications biology·2023
Same author

Double filtration plasmapheresis in hypertriglyceridemic pancreatitis: Triglyceride levels and clinical outcomes.

Journal of clinical apheresis·2020
Same author

Double filtration plasmapheresis: Review of current clinical applications.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·2020
Same author

Modification of the Dialysate Port of Plasma Separators for Safe Blood Purification in Japan.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·2018

Related Experiment Video

Updated: Feb 22, 2026

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

8.3K

Immunoadsorption using Immusorba TR and PH.

Ryuichiro Hirano1, Noriko Hirata2

  • 1International Disposable Product Marketing Department, Asahi Kasei Medical Co., Ltd., Japan.

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
|September 20, 2017
PubMed
Summary

Immusorba TR and PH are nonbiological immunoadsorbents using tryptophan or phenylalanine ligands to remove pathogenic substances. These treatments target autoimmune neurological and rheumatic diseases, aiding in disease pathogenesis research.

Keywords:
AutoantibodyImmunoadsorbentPhenylalaninePolyvinyl alcohol gelTryptophan

More Related Videos

Determining the Phagocytic Activity of Clinical Antibody Samples
09:05

Determining the Phagocytic Activity of Clinical Antibody Samples

Published on: November 30, 2011

24.1K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.6K

Related Experiment Videos

Last Updated: Feb 22, 2026

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

8.3K
Determining the Phagocytic Activity of Clinical Antibody Samples
09:05

Determining the Phagocytic Activity of Clinical Antibody Samples

Published on: November 30, 2011

24.1K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.6K

Area of Science:

  • Biomaterials Science
  • Immunology
  • Clinical Therapeutics

Background:

  • Autoimmune diseases involve pathogenic substances that can be targeted for removal.
  • Nonbiological immunoadsorbents offer an alternative to biological treatments.
  • Immusorba TR (IM-TR) and Immusorba PH (IM-PH) were developed as novel immunoadsorbent therapies.

Purpose of the Study:

  • To describe the development and application of Immusorba TR and Immusorba PH.
  • To highlight their efficacy in treating autoimmune neurological and rheumatic diseases.
  • To explore their potential in identifying unknown pathogenic substances and elucidating disease mechanisms.

Main Methods:

  • Immusorba TR and IM-PH utilize tryptophan and phenylalanine, respectively, as affinity ligands.
  • These ligands are immobilized on a polyvinyl alcohol gel matrix.
  • Clinical applications involve extracorporeal removal of pathogenic substances from patient blood.

Main Results:

  • IM-TR is primarily used for autoimmune neurological conditions like myasthenia gravis, Guillain-Barré syndrome, and multiple sclerosis.
  • IM-PH is applied to neurological and rheumatic diseases, including rheumatoid arthritis and systemic lupus erythematosus.
  • Autoantibodies with diverse specificities show significant affinity for Immusorba ligands.

Conclusions:

  • Immusorba TR and PH are effective nonbiological immunoadsorbents for treating various autoimmune diseases.
  • The broad affinity of Immusorba ligands suggests potential for wider therapeutic applications.
  • Adsorbed substances can provide insights into disease pathogenesis, facilitating the identification of unknown pathogenic factors.